1,469 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Piscataqua Savings Bank

Piscataqua Savings Bank purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,469 shares of the company’s stock, valued at approximately $119,000.

Several other large investors have also recently modified their holdings of the stock. Gradient Investments LLC purchased a new stake in shares of GE HealthCare Technologies during the second quarter valued at approximately $37,000. Peoples Financial Services CORP. purchased a new stake in shares of GE HealthCare Technologies during the second quarter worth about $64,000. Worth Asset Management LLC bought a new stake in shares of GE HealthCare Technologies in the second quarter worth about $83,000. Boit C F David bought a new position in GE HealthCare Technologies during the 2nd quarter valued at approximately $102,000. Finally, Sanders Morris Harris LLC bought a new position in GE HealthCare Technologies during the 2nd quarter valued at approximately $201,000. Hedge funds and other institutional investors own 79.18% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on GEHC. Wells Fargo & Company assumed coverage on GE HealthCare Technologies in a report on Wednesday, August 16th. They set an “overweight” rating and a $90.00 target price for the company. Argus began coverage on shares of GE HealthCare Technologies in a research report on Friday, August 25th. They issued a “buy” rating and a $80.00 target price on the stock. Bank of America assumed coverage on GE HealthCare Technologies in a research report on Monday, July 31st. They set a “neutral” rating and a $82.00 price objective for the company. Citigroup initiated coverage on GE HealthCare Technologies in a research note on Tuesday. They issued a “buy” rating and a $82.00 target price on the stock. Finally, Morgan Stanley assumed coverage on shares of GE HealthCare Technologies in a research report on Tuesday, June 27th. They set an “equal weight” rating on the stock. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $88.44.

GE HealthCare Technologies Trading Down 0.2 %

Shares of GE HealthCare Technologies stock opened at $66.28 on Tuesday. GE HealthCare Technologies Inc. has a fifty-two week low of $53.00 and a fifty-two week high of $87.83. The company has a current ratio of 1.22, a quick ratio of 0.92 and a debt-to-equity ratio of 1.44. The firm has a 50-day simple moving average of $73.08 and a two-hundred day simple moving average of $77.01.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Tuesday, July 25th. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.05. The firm had revenue of $4.82 billion for the quarter, compared to analyst estimates of $4.79 billion. GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 3.8 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, August 15th. Investors of record on Friday, July 21st were issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.18%. The ex-dividend date of this dividend was Thursday, July 20th.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Kevin Michael O’neill sold 15,609 shares of the stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $77.32, for a total transaction of $1,206,887.88. Following the completion of the transaction, the chief executive officer now owns 24,025 shares of the company’s stock, valued at $1,857,613. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.21% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.